The Saturday Morning Refill That Wasn't
A community pharmacy in Tampa is staffed by a single pharmacist, Dr. Reyes, and one technician on Saturday. At 9:10 a.m. a regular patient, Mr. Alvarez, presents a written prescription for alprazolam 1 mg, #60, dated 11 days earlier by a physician in a neighboring county. The prescription bears the physician's DEA number, address, and a handwritten signature; the quantity is written as '60 (sixty)' and the directions read '1 tab TID PRN anxiety.' Dr. Reyes checks the PDMP and sees that Mr. Alvarez filled the same drug and strength 9 days ago at another pharmacy, quantity 90, with a different prescriber. Mr. Alvarez says his new doctor increased his dose and that his old doctor 'doesn't need to know.' The pharmacy's wholesaler delivery is not due until Monday, and the shelf stock of alprazolam 1 mg is 45 tablets.
1. Can Dr. Reyes dispense this prescription today as written? Identify every legal and clinical obstacle and state what she may lawfully do.
Read the worked answer
Several independent issues must be resolved before any dispensing:
- Schedule IV validity. Alprazolam is Schedule IV under both Florida and federal law. A written prescription for a Schedule IV drug is valid, but Florida requires the prescription to be filled within a limited period - a Schedule IV prescription may not be filled more than 90 days after the date of issue (and a Schedule II prescription generally within 7 days). Eleven days is within the window, so timing alone is not disqualifying.
- Prescriber legitimacy. The prescriber is in a different county and is not the prescriber of the patient's prior fill. Dr. Reyes has a corresponding responsibility to resolve the apparent therapeutic inconsistency before dispensing. She should verify the prescriber's DEA registration and authority directly with the prescriber (not the patient), and document the conversation.
- PDMP review. Florida requires pharmacists to consult the PDMP before dispensing a controlled substance and to review it for indicators of misuse. The 9-day-old fill of 90 tablets plus this new 60-tablet prescription for the same drug is a red flag requiring resolution - either a documented legitimate change in therapy or a refusal.
- Quantity/stock. Only 45 tablets are on hand. A pharmacist may dispense a partial quantity of a Schedule II prescription under defined circumstances, but for a Schedule IV drug the cleaner path is to dispense the full quantity only when stock is available, or to obtain the balance and dispense in full. Dispensing 45 and promising the rest creates recordkeeping and 'partial fill' ambiguity that should be avoided unless the patient agrees and the pharmacist documents it.
- Forgery indicators. The quantity written both numerically and in words is good practice, but 'TID PRN' for a benzodiazepine plus the patient's statement that the old prescriber 'doesn't need to know' warrants direct prescriber contact.
Bottom line: Dr. Reyes should not dispense until she has spoken with the prescriber, confirmed the prescription's legitimacy and the dose change, reviewed and documented the PDMP findings, and resolved the stock shortfall. If the prescriber cannot be reached or the explanation is unsatisfactory, she should decline to fill and document the reason.
2. Assume Dr. Reyes verifies the prescription and decides to fill it. The patient is in a hurry and asks her to skip the counseling because 'I've taken this for years.' May she?
Read the worked answer
No. Florida law requires a pharmacist (or a person acting under the direct supervision of a pharmacist) to offer patient counseling on the proper use of the drug, its expected effects, and any special directions, at the time a prescription is dispensed. The offer must be made; the patient may decline. The pharmacist should document that counseling was offered and that the patient declined.
Practical points:
- The offer should be made in a manner that gives the patient a meaningful opportunity to ask questions - a hurried 'you good?' at the counter is not adequate.
- For a Schedule IV benzodiazepine, counseling should cover sedation, avoiding alcohol, driving precautions, dependence risk, and the interaction with any other CNS depressants on the patient's profile.
- The pharmacist should also counsel on the dose change from the prior fill, since the patient is transitioning from a different prescriber and quantity.
Documentation of the offer and the patient's response protects the pharmacist if a dispute arises later.